The U.S. Department of Health and Human Services has proposed a new rule to severely weaken the Affordable Care Act’s prohibitions against discrimination in health care, and to erase references to protections against discrimination by health care programs on the basis of gender identity or sex stereotype in regulations. These protections are provided under Section 1557 of the Affordable Care Act and its regulations.
In this June 12, 2019 testimony before the U.S. House of Representatives Energy and Commerce Subcommittee on Health, Claire McAndrew, Director of Campaigns and Partnerships at Families USA, breaks down the problem with surprise medical bills and potential solutions under consideration by the committee.
Families USA led 45 national organizations in the attached letter urging the Senate to swiftly take up recently House-passed proposals in H.R. 986 and H.R. 987 that improve health care coverage and access and undo administrative sabotage.
Families USA files amicus in Columbus et al. v. Trump (“Take Care”) case
A coalition of cities (Columbus, Baltimore, Cincinnati, Chicago, and Philadelphia) and two individuals filed a lawsuit challenging the Trump Administrations' many rules and administrative actions that sabotage the Affordable Care Act. The suit alleges that President Trump’s actions violate the President’s constitutional duty to “take care that the laws [of the United States] be faithfully executed.”
This webinar highlights current efforts to add oral health coverage to Medicare, improve Medicaid dental coverage for adults, and discusses how advocates can get involved in bringing attention to the need for Oral Health for All.
Open Application Programming Interfaces (APIs) for Medicare Advantage, Medicaid, Children Health Insurance Program, Qualified Health Plan Issuers in Federal Facilitated Exchanges and Enrollee and Beneficiary Resources Regarding Privacy and Security
Families USA recently commented on a proposed CMS regulation aimed at promoting the interoperability of health information technology (health IT).
The Utah Department of Medicaid released its much-anticipated proposal for a Section 1115 Medicaid waiver seeking a “per capita cap” – or a limit on federal spending – on major portions of its Medicaid program. If approved by the Trump administration, it would set a new precedent that could have catastrophic effects for state budgets and Medicaid programs in the future.
One of the strangest chapters in the Affordable Care Act’s history began a few hours after midnight on October 13, 2017. At 2:36 am, a Presidential tweet announced the end of cost-sharing-reduction (CSR) payments to insurers: “The Democrats [sic] ObamaCare is imploding. Massive subsidy payments to their pet insurance companies has [sic] stopped. Dems should call me to fix!” Later that morning, officials at the Department of Health and Human Services explained that the federal government would soon stop reimbursing insurers to cover the cost of giving low-income consumers legally-required reductions in out-of-pocket cost-sharing.
On May 16th, the Centers for Medicare and Medicaid Services announced a final regulation for Medicare’s Part D drug benefit for 2020. The regulation backed off of a proposal that would have created significant exceptions to requirements that Part D plans cover all drugs in six “protected classes”.
High and rising drug prices jeopardize consumers’ health and well-being.1 To address the harms of high drug prices, families across America want and deserve meaningful reforms that target and reduce the underlying “list” prices of drugs. Polling shows that nine out of 10 voters support allowing the government to negotiate lower drug prices in Medicare.2